“norbert-bischofberger” Archives

in
Entry Author Date Location
Bio Roundup: Moderna Publishes, Life Science Cash, AdComm Votes & More 07/17/20 National
Kronos Bio Reels In $105M for Drugs That Hit “Undruggable” Targets 07/18/19 San Francisco
Roche Vet O’Day Tapped to Shape Gilead’s Future as Hep C Sales Fall 12/10/18 San Francisco
Bio Roundup: Brii Does China, Hemophilia Updates, Right to Try & More 05/25/18 National
Nimbus’s LLC Origins Pay off As Gilead Shells Out $400M For Liver Drug 04/04/16 Boston
West Coast Biotech Roundup: Halozyme, Nektar, Allozyne, Novo & More 09/18/14 Seattle
Biotech and Fantasy Football Picks for Fall 2013 09/03/13 National
Gilead Wagers $600M on Calistoga, Dendreon Scopes New Digs, Physio to Spin Off, & More Seattle-Area Life Sciences News 02/24/11 Seattle
Gilead Pursues Cancer, Inflammation as Next Step To Diversify Beyond HIV 02/23/11 San Francisco
Calistoga Hands the Keys to Gilead, Bets It Can Make Cancer a Chronic Disease Like HIV 02/23/11 Seattle
Gilead Buys Calistoga Pharma for $375M, Making Move Into Cancer Drugs 02/22/11 Seattle
Gilead Cystic Fibrosis Drug Gets Green Light From FDA Panel 12/10/09 Seattle
Page 1 of 1